Paul Fortin

MD (Laval University, Québec)
MPH (Harvard University)

Professional Interests

clinical effectiveness, health services outcomes and evaluation, outcome in chronic rheumatic diseases, epidemiology of systemic autoimmune rheumatic disease, systemic lupus erythematosus

Impact

Dr. Fortin has been working on a better understanding of the bio-psycho-social impact of chronic rheumatic diseases such as systemic lupus erythematosus (SLE), the antiphospholipid antibody syndrome (APS), systemic autoimmune rheumatic diseases (SARD), osteoarthritis and rheumatoid arthritis. He is particularly interested in developing interventions for the treatment of SLE, APS and SARD.
His methodological interests cover the development and validation of health status measures and other clinical tools such as measures of disease activity or damage in SLE.  His other methodological interests include the development of risk profiles for arterial or venous thrombosis in APS, the testing of treatments of disease activity or cardiovascular disease in SLE, or the validation of biological markers in osteoarthritis.

Other Affiliations:

Hospital

Directeur adjoint de la recherche clinique, Centre de recherche du CHU de Québec, Québec, Canada
Staff Rheumatologist and Clinical Researcher, Division of Rheumatology and ‘Axe Maladies Infectieuses et Immunitaires’, CHU de Québec et Centre de recherche du CHU de Québec, Québec, Canada.

University

Tenured Professor, Faculté de Médicine, Université Laval, Québec, Canada.
Affiliate Rheumatologist and Scientist, Divisions of Rheumatology and Health Care and Outcomes Research, University Health Network (UHN) and UHN Research Institute, Toronto, Ontario, Canada
Adjunct Professor, Department of Medicine, University of Toronto, Toronto, Ontario, Canada

Awards and Distinctions (last 5 years)

INTERNATIONAL
2008 – 2010, The Kirkland Lupus Scholar Research Award, The Mary Kirkland Centre for Research and Rheuminations Inc. United States. (Research Award)

NATIONAL
2012 – present, Canada Research Chair in Systemic Autoimmune Rheumatic Diseases
2012 , 2012 Institute of Musculoskeletal Health Knowledge Translation Prize, Canadian Institutes of Health Research (Prize awarded to the Arthritis Research Centre of Canada)
2007 – 2012, istinguished Senior Research Investigator, The Arthritis Society of Canada, Canada. (Research Salary Award and Distinction)
2002 – 2007, Senior Investigator Award.  The Canadian Institutes of Health Research/The Arthritis Society of Canada, Canada. (Research Salary Award)

PROVINCIAL / REGIONAL
2010, The Hope Award, Lupus Ontario, Ontario, Canada. (Distinction)

Peer- Reviewed Grants- Funded (current)

2013 – 2018, Collaborator. An international, multi-center, prospective, inception cohort study of neuropsychiatric systemic lupus erythematosus (NPSLE) Canadian Institutes of Health Research. 1,329,295 CAD [Grants].

2013 – 2015, Principal Investigator. The Early Arthritis Screening & Treatment (EAST) program for Eastern Quebec. Canadian Initiative for Outcomes in Rheumatology Care. 120,000 CAD [Grants].

2012 – 2015, Co-Investigator. Developing Advanced Methods for Population-Based Comparative Effectiveness Studies. Canadian Institutes of Health Research. 950,000 CAD [Grants].

2012 – 2015, Co-Investigator. Identification of Biomarkers for Patient Stratification and Lupus Nephritis. Alliance for Lupus Research. 528,141 US [Grants].

2011 – 2014, Principal Investigator. Empowering Patients as Active Partners in Their Care:  Lupus Interactive Navigator (LIN).  Canadian Institutes of Health Research.  238692.  245,577 CAD. [Grants].

Publications

PubMed